共 84 条
[1]
Manning AP(1978)Towards a positive diagnosis of the irritable bowel Br Med J 2 653-654
[2]
Thompson WG(1999)Rome II: A multinational consensus document on functional gastrointestinal disorders Gut 45 1-81
[3]
Heaton KW(1987)Survey of the AGA membership relating to patients with functional gastrointestinal disorders Gastroenterology 92 1282-1284
[4]
Morris AF(1997)Irritable bowel syndrome: A technical review for practice guideline development Gastroenterology 112 2120-2137
[5]
Drossman DA(2002)The economic impact of irritable bowel syndrome in a managed care setting J Clin Gastroenterol 3 14-20
[6]
Corazziari E(2000)Economic burden of irritable bowel syndrome: Proposed strategies to control expenditures Pharmacoeconomics 4 331-338
[7]
Talley NJ(2001)Management of the irritable bowel syndrome Gastroenterology 120 652-668
[8]
Mitchell CM(2001)Lotronex Investigator Team: Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome Am J Gastroenterol 96 2662-2670
[9]
Drossman DA(2001)Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation Alim Pharm Ther 15 1655-1666
[10]
Drossman DA(1990)Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Relation to gynecologic features and outcome Dig Dis Sci 35 1285-1290